Effect of chronic ethanol administration on hepatic eNOS activity and its association with caveolin-1 and calmodulin in female rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 289, Issue 3 52-3, 2005, Pages

  Wang, Xu ^a   Abdel Rahman, Abdel A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Alcoholic liver injury; Endothelial nitric oxide synthase; Protein interactions

Indexed keywords

ALCOHOL; CALMODULIN; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HYPOTHESIS; LIVER; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; CALMODULIN; CAVEOLIN 1; CAVEOLINS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DIET; ETHANOL; FEMALE; LIVER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY;

EID: 24044551602     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00282.2004     Document Type: Article

References (37)

1. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124: 778-790, 2003.
2. Bautista AP and Spitzer JJ. Inhibition of nitric oxide formation in vivo enhances superoxide release by the perfused liver. Am J Physiol Gastrointest Liver Physiol 266: G783-G788, 1994.
3. Bist A, Fielding PE, and Fielding CJ. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc Natl Acad Sci USA 94: 10693-10698, 1997.
4. Bykov I, Jarvelainen H, and Lindros K. L-Carnitine alleviates alcohol-induced liver damage in rats: role of tumour necrosis factor-α. Alcohol Alcohol 38: 400-406, 2003.
5. Diehl AM. Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis. Alcohol Clin Exp Res 25: 8S-14S, 2001.
6. El-Mas MM and Abdel-Rahman AA. Role of aortic baroreceptors in ethanol-induced impairment of baroreflex control of heart rate in conscious rats. J Pharmacol Exp Ther 262: 157-165, 1992.
7. Fernandez Checa JC, Bellentani S, and Tiribelli C. Alcohol-induced liver disease: from molecular damage to treatment. Rev Med Chil 130: 681-690, 2002.
8. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, and Sessa WC. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 272: 25437-25440, 1997.
9. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, and Sessa WC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA 93: 6448-6453, 1996.
10. Garver WS, Erickson RP, Wilson JM, Colton TL, Hossain GS, Kozloski MA, and Heidenreich RA. Altered expression of caveolin-1 and increased cholesterol in detergent insoluble membrane fractions from liver in mice with Niemann-Pick disease type C. Biochim Biophys Acta 1361: 272-280, 1997.
11. Govers R and Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 280: F193-F206, 2001.
12. Hailstones D, Sleer LS, Parton RG, and Stanley KK. Regulation of caveolin and caveolae by cholesterol in MDCK cells. J Lipid Res 39: 369-379, 1998.
13. Ishak KG, Zimmerman HJ, and Ray MB. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res 15: 45-66, 1991.
14. Ju H, Zou R, Venema VJ, and Venema RC. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 272: 18522-18525, 1997.
15. Kim YM, Talanian RV, and Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272: 31138-31148, 1997.
16. Kimura H, Miura S, Higuchi H, Kurose I, Tsuzuki Y, Shigematsu T, Ebinuma H, Kato S, and Ishii H. Effect of chronic ethanol feeding on nitric oxide synthesis by rat Kupffer cells. Alcohol Clin Exp Res 20: 69A-72A, 1996.
17. Kurose I, Higuchi H, Miura S, Saito H, Watanabe N, Hokari R, Hirokawa M, Takaishi M, Zeki S, Nakamura T, Ebinuma H, Kato S, and Ishii H. Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology 25: 368-378, 1997.
18. Loureiro-Silva MR, Cadelina GW, and Groszmann RJ. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Am J Physiol Gastrointest Liver Physiol 284: G567-G574, 2003.
19. Lu SC, Tsukamoto H, and Mato JM. Role of abnormal methionine metabolism in alcoholic liver injury. Alcohol 27: 155-162, 2002.
20. Michel JB, Feron O, Sase K, Prabhakar P, and Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 272: 25907-25912, 1997.
21. Murata T, Sato K, Hori M, Ozaki H, and Karaki H. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J Biol Chem 277: 44085-44092, 2002.
22. Nanji AA, Greenberg SS, Tahan SR, Fogt F, Loscalzo J, Sadrzadeh SM, Xie J, and Stamler JS. Nitric oxide production in experimental alcoholic liver disease in the rat: role in protection from injury. Gastroenterology 109: 899-907, 1995.
23. Nishida J, McCuskey RS, McDonnell D, and Fox ES. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol Gastrointest Liver Physiol 267: G1135-G1141, 1994.
24. Ortiz PA and Garvin JL. Trafficking and activation of eNOS in epithelial cells. Acta Physiol Scand 179: 107-114, 2003.
25. Oshita M, Takei Y, Kawano S, Hijioka T, Masuda E, Nishimura Y, Fusamoto H, and Kamada T. Role of nitric oxide in ethanol-induced perturbation of hepatic microcirculation in rat liver. Alcohol Alcohol Suppl 2: 353-356, 1994.
26. Rambaldi A, Iaquinto G, and Gluud C. Anabolic-androgenic steroids for alcoholic liver disease. Cochrane Database Syst Rev 1: CD003045, 2003.
27. Rockey DC and Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 114: 344-351, 1998.
28. Sessa WC. The nitric oxide synthase family of proteins. J Vasc Res 31: 131-143, 1994.
29. Shah V, Cao S, Hendrickson H, Yao J, and Katusic ZS. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am J Physiol Gastrointest Liver Physiol 280: G1209-G1216, 2001.
30. Shah V, Garcia-Cardena G, Sessa WC, and Groszmann RJ. The hepatic circulation in health and disease: report of a single-topic symposium. Hepatology 27: 279-288, 1998.
31. Shah V, Haddad FG, Garcia-Cardena G, Frangos JA, Mennone A, Groszmann RJ, and Sessa WC. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 100: 2923-2930, 1997.
32. Shah V, Toruner M, Haddad F, Cadelina G, Papapetropoulos A, Choo K, Sessa WC, and Groszmann RJ. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology 117: 1222-1228, 1999.
33. Shaw SL, Salmon ED, and Quatrano RS. Digital photography for the light microscope: results with a gated, video-rate CCD camera and NIH-image software. Biotechniques 19: 946-955, 1995.
34. Tsutsumi M and Takase S. Effect of fenofibrate on fatty liver in rats treated with alcohol. Alcohol Clin Exp Res 25: 75S-79S, 2001.
35. Wang X and Abdel-Rahman AA. Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts. Am J Physiol Heart Circ Physiol 282: H2309-H2315, 2002.
36. Wang XD. Chronic alcohol intake interferes with retinoid metabolism and signaling. Nutr Rev 57: 51-59, 1999.
37. Yu Q, Shao R, Qian HS, George SE, and Rockey DC. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. J Clin Invest 105: 741-748, 2000.